Abstracts

Instructions

Important dates not to miss

07/03/2025 Submission Deadline

21/03/2025 Starting to send the notifications of Acceptance/Decline.

Please allow 2-3 days to receive your email.

31/03/2025 Deadline for the First Author to be registered for the congress

1.- GENERAL INSTRUCTIONS FOR ALL SUBMISSIONS

The person designated as the First Author of an accepted Abstract will be granted a 15% discount on her/his congress registration.

All abstracts must be uploaded in the designated MyGCH section differentiated by Video, Poster, or Oral Abstract. Documents sent using other methods won't be considered. In order to submit an abstract, you need to hold a free account in MyGCH. If you don't have one yet, click Join MyGCH and follow the steps.

------------------------

1) As usual, if the abstract is accepted, the First Author will have to be registered for the congress by the given deadline in order for the work to be published. Failure to meet deadlines will result in exclusion from any presentation or submission for publication. All accepted communications will be published/shared during GCH2025.

2) Technical Requirements:

Language: All abstracts and communications MUST be in English.
Abstract submission: All Oral, Poster, and Video Presentations need to submit an abstract. Video Presentations additionally, need to submit the presented video.
Disclosure: The submitting author is responsible for reporting the disclosure information for each named author. Disclosure of all authors is a step that must be completed in the abstract submission.
Scientific nature: Any communication that is more advertising-oriented than scientific in nature will be rejected.
IRB (Institutional Review Board) Approval: IRB approval or waiver is required for the submission of clinical research abstracts. You will be required to indicate whether your study has been IRB-reviewed.
Every communication must cover these areas:

Aim: indicate the purpose and objective of the research, the hypothesis that was tested, or a description of the problem being analyzed or evaluated.
Method: describe the study period/setting/location, study design, data collection, and methods of analysis used.
Results: present as clearly and in as much detail as possible the findings/outcome of the study. Please summarize any specific results.
Conclusions: explain the significance of your findings/outcomes and future implications of the results.

3) The Global Congress on Hysteroscopy welcomes VIDEO, ORAL, and POSTER communications in the following categories:

Submucosal Fibroids & Polyps.
Hysteroscopy and Fertility.
Hysteroscopy in Oncology.
Hysteroscopy; Innovation, Simulation, and Education.
AI in Hysteroscopy.
Hysteroscopy Complications.
Hysteroscopy and Mullerian anomalies.
Hysteroscopy and Contraception.
Hysteroscopic Instrumentation.
Office Hysteroscopy, Vaginoscopy, and Pain Control.
Other related of similar interest

4) REMINDER: The deadline for Abstracts Submission is Friday, 7th March 2025, 11:59:59 p.m. CET. After that, works will no longer be accepted.

2.- DISCLOSURE PROCEDURE FOR ALL COMMUNICATIONS

1) Reporting of Disclosures

This process is meant to ensure that anyone who is in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest (see below for definitions) as it pertains to the content of the presentation. Should it be determined that a conflict of interest exists as a result of a financial relationship you may have, you will be contacted and methods to resolve the conflict will be discussed with you. In addition, full disclosures for all authors must be revealed by a slide at the beginning of the presentation. Failure or refusal to disclose or the inability to resolve the identified conflict may result in the withdrawal of the invitation to participate.

All authors for video/oral presentations are required to disclose ALL financial relationships with commercial interests involved in producing healthcare goods or services, active over the 12-MONTH period preceding the meeting whether or not this relationship is directly related to the material being presented. The abstract submitter must input the disclosure information for each named author prior to submission. Failure to comply with disclosure rules with complete honesty and openness will result in the individual forfeiting his or her right to present at the next congress. The organizing Committee has no issue with industrial affiliation, but they do with failure to disclose that affiliation. The audience MUST be given the tools with which to judge a presentation in light of the author’s interaction with the industry.

2) Commercial Interest

The ACCME defines a “commercial interest” as any proprietary entity producing healthcare goods or services, with the exemption of non-profit or government organizations and non-healthcare-related companies.

3) Financial relationships

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefits. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities for which remuneration is received, or expected. Financial relationships of the person involved in the congress include the financial relationships of a spouse or partner.

Contact secretary@my-gch.com with any Abstract-related questions you may have.

Please proceed to check below the specifications for each modality of communication

By modality

Video Communication

a) GCH2025-V | Key requirements

• For Abstract Submission, both the abstract in pdf and the link to the video must be presented for review.

• There's a limit of 500 words for the text of your abstract including the title and text body (does not include the author/s name/s).

• The video should be a maximum of 3 minutes in length. The eventual onsite presentation will last a maximum of 4 minutes plus 1 additional minute for questions, total 5 minutes.

· Reminder: All works must be in English.

• The video file size should be a maximum of 200 MB in weight.

• A participant may submit several individual Video Communications by uploading/filling out separate Abstract Submission Forms.

• All personal data related to the patient and/or examination (e.g. date, time, place, patient name, patient birth date, unique ID, examiner name or ID, institution) must be removed from videos before submission. Findings/diagnoses and markings such as arrows are allowed. If your image or video contains technical parameters, please make sure that they consist only of complete, recognizable data that are essential for understanding it. Proof of patient consent must be provided if the patient can be identified.

• The presentation MUST include at the beginning full disclosure information for ALL authors. All videos submitted for Video Communication without disclosures will not be considered.

• Videos with case series require IRB approval or waiver at the time of video abstract submission.

• For optimal video quality, please follow these specifications:

. Each video MUST be in the formats of *.avi *.mov *.mpg *.mp4 or *.WMV. The use of other formats may result in a loss of quality of the final output.

. Each video MUST have audio narration. Otherwise, it will not be considered for presentation. Background music is NOT allowed.

. Each video MUST include full disclosure information for ALL authors at the beginning of the video. All videos submitted without disclosures will not be considered for presentation.

. When a video is shot from its original source such as a camera, it should be recorded at the highest possible quality the camcorder can capture. The higher the resolution the better it will look on bigger screens. Also, it allows for room to degrade if the conversion is necessary.

Oral Communication

b) GCH2025-O | Key requirements

• For submission, only an abstract in pdf needs to be presented for approval.

• There's a limit of 500 words for the text of your abstract submission including the title and text body (does not include the author/s name/s).

• The content of your presentation needs to be displayed in a maximum of 10 slides. The duration of the eventual onsite presentation will be 5 minutes plus an additional 2 for Q&A, making a total of 7 minutes' presentation maximum.

· Reminder: All works must be in English.

• The file size should be a maximum of 200 MB in weight.

• A participant may submit several individual Oral Presentations by uploading/filling out separate Abstract Submission Forms.

• The presentation MUST include at the beginning full disclosure information for ALL authors. All videos submitted for Oral Presentation without disclosures will not be considered.

• Videos with case series require IRB approval or waiver at the time of video abstract submission.

• For optimal video quality, please follow these specifications:

. Each video MUST be in the formats of *.avi *.mov *.mpg *.mp4 or *.WMV. The use of other formats may result in a loss of quality of the final output.

. Each video MUST have audio narration. Otherwise, it won't be considered for presentation. Background music is NOT allowed.

. Each video MUST include full disclosure information for ALL authors at the beginning of the video. All videos submitted without disclosures will not be considered for presentation.

Poster

c) GCH2025-P | Key requirements

• In order to apply, only the abstract in pdf format needs to be presented for review.

• There's a limit of 500 words for the text of your abstract submission including the title and text body (does not include the author/s name/s).

• The accepted file format for the poster is pdf and size A3 Portrait (vertical), on a single page.

• The maximum weight of the poster file will be 10 MB.

· The Posters are not orally presented.

· Reminder: All works must be in English.

· There is no need to print the Poster. The Organization is in charge of printing and displaying the accepted works, in the designated area.

• A participant may submit several Posters by uploading/filling out separate Abstract Submission Forms.

• All personal data related to the patient and/or examination (e.g. date, time, place, patient name, patient birth date, unique ID, examiner name or ID, institution) must be removed before submission. Findings/diagnoses and markings such as arrows are allowed. If your image contains technical parameters, please make sure that they consist only of complete, recognizable data that are essential for understanding it. Proof of patient consent must be provided if the patient can be identified.